Form 4 for AGX ARGAN INC
Accepted 2026-01-14 00:00:00 ET · period of report 2026-01-13 · accession 0001463638-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-01-14 | 2026-01-13 | AGX | Flanders Cynthia | Dir | M - OptEx | $40.72 | +26.1K | 27.8K | +1,480% | +$1.06M |
| DM | 2026-01-14 | 2026-01-13 | AGX | Flanders Cynthia | Dir | M - OptEx | $40.77 | -30.0K | 6,500 | -82% | -$1.22M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-13 | M | A | 8,534 | $45.75 | 36,375 | D | — | — | (F2) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. |
| 2 | Common | Common Stock | 2026-01-13 | M | A | 4,405 | $37.13 | 40,780 | D | — | — | (F3) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. |
| 3 | Common | Common Stock | 2026-01-13 | M | A | 4,427 | $35.72 | 45,207 | D | — | — | (F4) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method. |
| 4 | Common | Common Stock | 2026-01-13 | M | A | 8,713 | $40.15 | 27,841 | D | — | — | (F1) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. |
| 5 | Derivative | Option to Purchase Common Stock | 2026-01-13 | M | D | 5,000 | $35.72 | 1,500 | D | $35.72 · 2023-12-16 to 2032-12-16 | 5,000 Common Stock | (F4) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 16, 2022 to purchase 5,000 shares of the Issuer's common stock at a price of $35.72 per share, using the net settle method. |
| 6 | Derivative | Option to Purchase Common Stock | 2026-01-13 | M | D | 10,000 | $45.75 | 11,500 | D | $45.75 · 2021-12-14 to 2030-12-14 | 10,000 Common Stock | (F2) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2020 to purchase 10,000 shares of the Issuer's common stock at a price of $45.75 per share, using the net settle method. |
| 7 | Derivative | Option to Purchase Common Stock | 2026-01-13 | M | D | 10,000 | $40.15 | 21,500 | D | $40.15 · 2020-12-23 to 2029-12-23 | 10,000 Common Stock | (F1) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 23, 2019 to purchase 10,000 shares of the Issuer's common stock at a price of $40.15 per share, using the net settle method. |
| 8 | Derivative | Option to Purchase Common Stock | 2026-01-13 | M | D | 5,000 | $37.13 | 6,500 | D | $37.13 · 2022-12-14 to 2031-12-14 | 5,000 Common Stock | (F3) On January 13, 2026, the Reporting Person exercised her stock option awarded on December 14, 2021 to purchase 5,000 shares of the Issuer's common stock at a price of $37.13 per share, using the net settle method. |